David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$667M |
| 2 |
NVIDIA
NVDA
|
+$584M |
| 3 |
ConocoPhillips
COP
|
+$432M |
| 4 |
Amazon
AMZN
|
+$418M |
| 5 |
Johnson & Johnson
JNJ
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$836M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
Apple
AAPL
|
+$453M |
| 4 |
CELG
Celgene Corp
CELG
|
+$349M |
| 5 |
Pfizer
PFE
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.27% |
| 2 | Consumer Discretionary | 13.7% |
| 3 | Healthcare | 13.3% |
| 4 | Industrials | 7.34% |
| 5 | Financials | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
Gates Industrial Corp
GTES
$6.5B
| $131K | ﹤0.01% |
+11,500
| New | +$155K |
|
3477
Precigen
PGEN
$2.55B
| $130K | ﹤0.01% |
+16,943
| New | +$91.2K |
|
|
HTT
3478
High Templar Tech Ltd
HTT
$388M
| $130K | ﹤0.01% |
17,351
-375,056
| -96% | -$2.58M |
|
|
GIX.U
3479
DELISTED
GigCapital2, Inc.
GIX.U
| $130K | ﹤0.01% |
+12,932
| New | +$130K |
|
|
AKS
3480
DELISTED
AK Steel Holding Corp
AKS
| $129K | ﹤0.01% |
54,398
-212,821
| -80% | -$496K |
|
3481
Kopin
KOPN
$894M
| $128K | ﹤0.01% |
117,138
+53,214
| +83% | +$64.7K |
|
|
NWHM
3482
DELISTED
THE NEW HOME COMPANY INC.
NWHM
| $128K | ﹤0.01% |
33,210
+23,140
| +230% | +$105K |
|
3483
Green Brick Partners
GRBK
$3.13B
| $127K | ﹤0.01% |
+15,249
| New | +$137K |
|
|
CPE
3484
PUT
DELISTED
Callon Petroleum Company
CPE
| $127K | ﹤0.01% |
1,920
-860
| -31% | -$62K |
|
|
ASNA
3485
DELISTED
Ascena Retail Group, Inc.
ASNA
| $125K | ﹤0.01% |
10,271
+2,185
| +27% | +$46.4K |
|
|
HDSN
3486
Hudson Technologies
HDSN
$232M
| $123K | ﹤0.01% |
+143,615
| New | +$228K |
|
3487
Amplify Energy
AMPY
$199M
| $121K | ﹤0.01% |
+20,532
| New | +$182K |
|
3488
Larimar Therapeutics
LRMR
$421M
| $121K | ﹤0.01% |
8,432
-2,552
| -23% | -$68K |
|
3489
Anavex Life Sciences
AVXL
$292M
| $120K | ﹤0.01% |
+35,587
| New | +$111K |
|
|
MACK
3490
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $119K | ﹤0.01% |
24,895
-110,648
| -82% | -$524K |
|
3491
Marker Therapeutics
MRKR
$24.8M
| $117K | ﹤0.01% |
+1,479
| New | +$87.8K |
|
3492
Teekay
TK
$1.18B
| $116K | ﹤0.01% |
+33,688
| New | +$130K |
|
|
QHC
3493
DELISTED
Quorum Health Corporation
QHC
| $116K | ﹤0.01% |
83,248
-206,591
| -71% | -$339K |
|
|
JAX
3494
DELISTED
J. Alexander's Holdings, Inc.
JAX
| $113K | ﹤0.01% |
+10,042
| New | +$108K |
|
3495
Gladstone Capital
GLAD
$446M
| $108K | ﹤0.01% |
5,741
-1,847
| -24% | -$34.4K |
|
3496
vTv Therapeutics
VTVT
$135M
| $108K | ﹤0.01% |
1,888
-357
| -16% | -$21.4K |
|
|
AFMD
3497
DELISTED
Affimed
AFMD
| $107K | ﹤0.01% |
3,731
+2,456
| +193% | +$82.7K |
|
|
BHR
3498
Braemar Hotels & Resorts
BHR
$140M
| $105K | ﹤0.01% |
+10,681
| New | +$127K |
|
|
CLUB
3499
DELISTED
Town Sports International Holdings, Inc.
CLUB
| $104K | ﹤0.01% |
+47,894
| New | +$160K |
|
|
EGLE
3500
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $104K | ﹤0.01% |
+2,829
| New | +$100K |
|
Similar funds
David Shaw's Q2 2019 Portfolio in Review
As of Q2 2019, David Shaw held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
- David Shaw added most to Alibaba in Q2 2019, an estimated $667M increase.
- David Shaw's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
- David Shaw's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
- David Shaw opened 499 new positions and closed 416 in Q2 2019.
- David Shaw's portfolio value rose 3.6% quarter-over-quarter to $80.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.